Acetyl-Histone H4 (K16) Antibody

What is Acetyl-Histone H4 (K16) and why is it important in epigenetic research?

Acetylation of histone H4 at lysine 16 (H4K16ac) represents a hyperacetylated state in histone H4 that strongly correlates with active gene states. Unlike other histone modifications, H4K16ac stands out because it directly decompacts the chromatin fiber, making it a critical epigenetic mark. This modification plays essential roles in:

• Chromatin structure regulation

• Transcriptional activation

• DNA repair processes

• Epigenetic signaling

• Cellular memory mechanisms

• Coordinated gene regulation

Notably, hypoacetylation of H4K16 is commonly found in human tumors, making this modification an important research target for understanding disease mechanisms .

What applications can Acetyl-Histone H4 (K16) antibodies be used for?

Acetyl-Histone H4 (K16) antibodies can be used in multiple research applications, with varying recommended dilutions:

These applications enable researchers to investigate H4K16ac in various experimental contexts, from global protein levels to genomic distribution patterns .

How do you select between monoclonal and polyclonal Acetyl-Histone H4 (K16) antibodies?

Selection between monoclonal and polyclonal antibodies should be based on experimental requirements:

Monoclonal antibodies (e.g., Rabbit mAb #13534):

• Provide superior lot-to-lot consistency

• Offer continuous supply through recombinant production

• Typically demonstrate higher specificity for the acetylated K16 epitope

• Recommended for precise quantitative analyses and ChIP applications

• Animal-free manufacturing options are available

Polyclonal antibodies (e.g., Rabbit pAb A5280):

• Recognize multiple epitopes on the target, potentially increasing sensitivity

• May exhibit broader cross-reactivity with related histone modifications

• Useful when signal amplification is needed

• Can be more suitable for detecting low-abundance modifications

For critical research requiring high specificity, recombinant monoclonal antibodies generally provide more reliable results, while polyclonal antibodies may offer advantages in detection sensitivity .

What controls should be included when working with Acetyl-Histone H4 (K16) antibodies?

Proper experimental controls are essential for valid interpretation of results:

• Positive controls:

  • Cells treated with HDAC inhibitors (e.g., TSA at 1 μM for 18 hours) to increase H4K16ac levels

  • NIH/3T3 and C6 cells treated with TSA show increased H4K16ac signal in immunofluorescence and Western blot

• Negative controls:

  • Primary antibody omission

  • Non-specific IgG from the same species

  • Untreated cells (compared to HDAC inhibitor-treated cells)

  • HAT inhibitor-treated samples (reduces H4K16ac)

• Specificity controls:

  • Peptide competition assays using acetylated and non-acetylated H4K16 peptides

  • Western blot showing expected 11 kDa band

  • Knockout/knockdown of H4K16 acetyltransferases (e.g., MOF/KAT8)

These controls help verify antibody specificity and validate experimental findings across different applications .

How does H4K16 acetylation affect chromatin structure and function?

H4K16 acetylation has unique effects on chromatin architecture:

• Chromatin decompaction: Unlike other histone modifications, H4K16ac directly disrupts higher-order chromatin structure by preventing the interaction between the H4 tail and acidic patches on adjacent nucleosomes .

• Nucleosome dynamics: H4K16ac reduces nucleosome stability and increases DNA accessibility, facilitating the binding of transcription factors and chromatin remodelers.

• Higher-order structure: Acetylation at K16 prevents the formation of compact 30nm fibers, resulting in a more open chromatin conformation that is permissive for transcription.

• Boundary element function: H4K16ac can act as a boundary element, separating active and repressive chromatin domains.

• Interaction with chromatin regulators: This modification serves as a binding platform for specific reader proteins containing bromodomains, while preventing binding of repressive complexes like Sir3 in yeast .

These structural changes establish a direct mechanistic link between H4K16 acetylation and transcriptional activation .

What is the relationship between H4K16ac and human disease, particularly cancer?

H4K16ac dysregulation has significant implications in human disease:

• Cancer biomarker: Hypoacetylation of H4K16 is commonly observed in human tumors and may serve as a cancer biomarker .

• Tumor suppression: Loss of H4K16ac correlates with silencing of tumor suppressor genes and genomic instability.

• MOF dysregulation: Altered expression or activity of MOF (KAT8), the primary H4K16 acetyltransferase, occurs in various cancers.

• Therapeutic target: Modulating H4K16ac levels through HDAC inhibition represents a potential therapeutic approach. TSA treatment increases H4K16ac levels in experimental models .

• DNA damage response: H4K16ac plays critical roles in DNA repair processes, and its dysregulation contributes to genomic instability in cancer cells.

• Cancer progression mechanisms: H4K16 acetylation status influences cancer cell proliferation, migration, and resistance to therapy.

Understanding these relationships provides opportunities for developing epigenetic-based diagnostic and therapeutic strategies in cancer research .

How can ChIP-seq protocols be optimized for H4K16ac detection?

Optimizing ChIP-seq for H4K16ac requires attention to several critical parameters:

• Antibody selection: Use highly specific monoclonal antibodies validated for ChIP applications, such as E2B8W Rabbit mAb (CSB-RA010429A16acHU or Cell Signaling #13534) .

• Crosslinking conditions: Adjust formaldehyde concentration (0.5-1%) and fixation time (10-15 minutes) to preserve H4K16ac epitopes while ensuring adequate chromatin capture.

• Chromatin fragmentation: Optimize sonication conditions to generate 200-500bp fragments without epitope destruction. Monitor fragment size distribution by gel electrophoresis.

• Immunoprecipitation conditions:

  • Use specialized buffers with HDAC inhibitors (e.g., sodium butyrate)

  • Optimize antibody concentration (typically 2-5μg per ChIP reaction)

  • Include protease inhibitors and phosphatase inhibitors in all buffers

  • Extend incubation time (overnight at 4°C) for efficient binding

• Washing stringency: Balance between removing non-specific binding and preserving specific interactions.

• Controls: Include input DNA, IgG controls, and spike-in normalization standards.

• Library preparation: Use methods optimized for limited DNA input when necessary.

These optimizations help ensure high-quality H4K16ac ChIP-seq data with minimal background and maximum signal-to-noise ratio .

What are the known cross-reactivity issues with H4K16ac antibodies and how can they be addressed?

H4K16ac antibodies may exhibit several cross-reactivity issues that require careful consideration:

• Cross-reactivity with other lysine acetylation sites on H4:

  • H4K5ac, H4K8ac, and H4K12ac occur on the same histone tail

  • Some antibodies, particularly polyclonals, may recognize these neighboring acetylation sites

• Recognition of acetylated lysines on other histones:

  • Similar sequence contexts around acetylated lysines can lead to cross-reactivity

  • Particularly problematic with less specific polyclonal antibodies

• Epitope masking due to adjacent modifications:

  • Phosphorylation or methylation of nearby residues may affect antibody binding

  • Combinatorial modifications can alter epitope accessibility

Mitigation strategies include:

• Using highly specific monoclonal antibodies with validated specificity profiles

• Performing peptide competition assays with acetylated and non-acetylated peptides

• Including appropriate controls (e.g., MOF knockout samples lacking H4K16ac)

• Using mass spectrometry-based validation when absolute specificity is required

• Comparing results from multiple antibodies targeting the same modification

Researchers should examine the validation data provided by manufacturers and perform their own validation experiments in their specific biological context .

How is H4K16 acetylation regulated by MOF and other acetyltransferases?

H4K16 acetylation is regulated through complex enzymatic networks:

• MOF (KAT8) as the primary acetyltransferase:

  • MOF in the male-specific lethal core (4-MSL) complex specifically targets H4K16

  • Part of the Dosage Compensation Complex (DCC) in Drosophila

  • Questions remain about the selectivity of MOF for the H4 N-terminus

  • Targeted mass spectrometry has been used to examine MOF activity on nucleosome arrays

• Other acetyltransferases with H4K16 activity:

  • Tip60 complex can acetylate H4K16 in specific contexts

  • Specific HAT inhibitors can be used to distinguish different enzymatic contributions

• Regulation of MOF activity:

  • Complex formation (MSL, NSL) influences substrate specificity

  • Post-translational modifications affect enzymatic activity

  • Interaction with chromatin remodeling factors modulates targeting

• Deacetylation dynamics:

  • Multiple HDACs (HDAC1, SIRT1, SIRT2) remove acetyl groups from H4K16

  • HDAC inhibitors like TSA increase global H4K16ac levels

  • Deacetylation is often coupled with repressive chromatin states

Understanding these regulatory mechanisms provides insights into normal chromatin function and disease processes where H4K16ac is dysregulated .

What are the optimal conditions for immunofluorescence detection of H4K16ac?

Successful immunofluorescence detection of H4K16ac requires careful optimization:

• Fixation protocol:

  • 4% paraformaldehyde for 10-15 minutes at room temperature

  • Alternative: methanol fixation (-20°C for 10 minutes) for better nuclear permeabilization

• Permeabilization:

  • 0.2-0.5% Triton X-100 in PBS for 10 minutes

  • Critical for antibody access to nuclear epitopes

• Blocking conditions:

  • 3-5% BSA or 5-10% normal serum in PBS with 0.1% Triton X-100

  • 1-2 hours at room temperature or overnight at 4°C

• Antibody dilutions and incubation:

  • Primary antibody: 1:50-1:200 dilution in blocking buffer

  • Incubation: Overnight at 4°C in a humidified chamber

  • Secondary antibody: Cy3-conjugated anti-rabbit IgG at 1:500 dilution

  • Secondary incubation: 1-2 hours at room temperature

• Nuclear counterstaining:

  • DAPI (blue) for nuclear visualization

  • Important for co-localization analysis

• Controls:

  • TSA-treated cells (1 μM for 18 hours) as positive control

  • Untreated cells for baseline comparison

  • Primary antibody omission control

These conditions have been validated in multiple cell lines including C6, NIH/3T3, and U-2 OS cells, with successful detection of nuclear H4K16ac signals .

How should samples be prepared for optimal Western blot detection of H4K16ac?

Sample preparation is critical for successful Western blot detection of H4K16ac:

• Histone extraction protocol:

  • Acid extraction method:

    • Lyse cells in Triton Extraction Buffer (PBS with 0.5% Triton X-100, 2mM PMSF, 0.02% NaN₃)

    • Extract histones with 0.2N HCl overnight at 4°C

    • Precipitate with TCA and wash with acetone

  • Commercial histone extraction kits also provide good results

• Protein quantification:

  • Bradford or BCA assay adjusted for acidic samples

  • Load 10-25μg of histone extract per lane

• Gel electrophoresis conditions:

  • 15-18% SDS-PAGE gels for optimal separation of small histone proteins

  • Include loading controls (total H4 or H3)

• Transfer parameters:

  • PVDF membrane (0.2μm pore size)

  • Transfer in 25mM Tris, 192mM glycine, 20% methanol

  • 100V for 1 hour or 30V overnight at 4°C

• Blocking and antibody incubation:

  • Block in 3-5% non-fat dry milk in TBST

  • Primary antibody: 1:100-1:500 dilution in blocking buffer

  • Incubation: Overnight at 4°C

  • Secondary antibody: HRP-conjugated anti-rabbit IgG at 1:10,000

• Detection considerations:

  • ECL-based detection systems work well

  • Expected molecular weight: 11 kDa

• Validation controls:

  • TSA-treated cells (1μM, 18 hours) show increased H4K16ac signal

  • Compare NIH/3T3 and C6 treated vs. untreated cells

This protocol has been validated for detecting endogenous H4K16ac in various cell types and provides consistent results .

How can the specificity of Acetyl-Histone H4 (K16) antibodies be validated?

Comprehensive validation of H4K16ac antibodies requires multiple approaches:

• Peptide competition assays:

  • Pre-incubate antibody with acetylated H4K16 peptide

  • Pre-incubate with unmodified H4K16 peptide as control

  • Compare signal reduction between conditions

• Genetic validation:

  • Use MOF/KAT8 knockout or knockdown cells (reduced H4K16ac)

  • Compare with wild-type cells to confirm specificity

  • Rescue experiments with re-expression of MOF

• Treatment validation:

  • HDAC inhibitors (TSA 1μM for 18 hours) increase H4K16ac

  • HAT inhibitors decrease H4K16ac

  • Observe expected changes in signal intensity

• Cross-reactivity testing:

  • Test against peptide arrays containing various histone modifications

  • Evaluate specificity against other acetylated lysines on H4 (K5, K8, K12)

  • Western blot should show a single band at 11 kDa

• Mass spectrometry confirmation:

  • Immunoprecipitate histones with the antibody

  • Analyze by MS to confirm specific enrichment of H4K16ac peptides

  • Targeted MS can provide quantitative validation of antibody specificity

• Application-specific validation:

  • For ChIP applications, include IgG controls and input normalization

  • For immunofluorescence, include peptide competition controls

  • For Western blots, compare with other validated H4K16ac antibodies

These validation approaches ensure that experimental results accurately reflect H4K16ac biology rather than antibody artifacts .

How do I interpret changes in H4K16ac signals across different experimental conditions?

Proper interpretation of H4K16ac data requires consideration of multiple factors:

• Baseline considerations:

  • Different cell types have variable baseline H4K16ac levels

  • Cell cycle phase affects global H4K16ac (typically higher in S phase)

  • Confluency and growth conditions influence acetylation levels

• Signal quantification:

  • For Western blots: normalize H4K16ac to total H4

  • For IF/ICC: measure nuclear signal intensity across >100 cells

  • For ChIP: normalize to input and account for technical variation

• Pattern interpretation:

  • Global increase: often indicates HDAC inhibition or general transcriptional activation

  • Global decrease: may reflect HAT inhibition or repressive conditions

  • Locus-specific changes: correlate with gene expression changes

  • Redistribution: may indicate altered targeting of HATs/HDACs

• Biological significance thresholds:

  • 1.5-2 fold changes are typically considered biologically significant

  • Statistical analysis should account for biological replicates (n≥3)

  • Small but consistent changes may be functionally important

• Integration with other data:

  • Correlate with gene expression data

  • Compare with other histone modifications

  • Consider in the context of chromatin accessibility data

• Causality vs. correlation:

  • Changes in H4K16ac may be cause or consequence of other processes

  • Intervention studies (e.g., targeted HAT/HDAC recruitment) help establish causality

These analytical frameworks help distinguish biologically meaningful changes from technical variation and provide context for interpreting experimental results .

What are the best bioinformatic approaches for analyzing H4K16ac ChIP-seq data?

Analysis of H4K16ac ChIP-seq data requires specialized bioinformatic approaches:

• Quality control and preprocessing:

  • FastQC for sequence quality assessment

  • Adapter trimming with Trimmomatic or Cutadapt

  • Alignment to reference genome using Bowtie2 or BWA

  • Remove duplicates with Picard tools

  • Filter for mapping quality (MAPQ>30)

• Peak calling strategies:

  • Broad peak callers (MACS2 with --broad flag, SICER) work better than narrow peak callers

  • Use appropriate control (input DNA or IgG ChIP)

  • Adjust false discovery rate (typically q<0.05 or q<0.01)

• Differential binding analysis:

  • DiffBind or MAnorm for comparing H4K16ac across conditions

  • DESeq2 or edgeR for statistical assessment of differences

  • Consider using spike-in normalization for quantitative comparisons

• Genomic feature association:

  • GREAT or ChIPseeker for associating peaks with genomic features

  • Profile TSS enrichment patterns (typically bimodal)

  • Analyze enhancer-associated H4K16ac separately from promoter regions

• Integration with other data types:

  • Correlation with RNA-seq for expression relationships

  • Integration with other histone marks (H3K4me3, H3K27ac) using multivariate approaches

  • Chromatin state analysis with ChromHMM or Segway

• Visualization strategies:

  • Genome browsers (IGV, UCSC) for locus-specific views

  • Heatmaps centered on TSSs or other features

  • Average profile plots showing H4K16ac distribution

• Motif analysis:

  • MEME, HOMER, or JASPAR for identifying enriched transcription factor motifs

  • Can provide insights into factors recruiting HATs/HDACs

These approaches enable comprehensive analysis of H4K16ac distribution and its relationship to gene regulation and chromatin structure .

How can H4K16ac patterns be correlated with gene expression and other functional genomic data?

Integrating H4K16ac data with other functional genomics datasets yields deeper biological insights:

• Correlation with transcriptional activity:

  • Calculate H4K16ac enrichment in promoter regions (±2kb around TSS)

  • Correlate with RNA-seq or microarray expression data

  • Group genes by expression level and examine H4K16ac patterns

  • Expected pattern: positive correlation between H4K16ac and gene expression

• Integration approaches:

  • Direct correlation: Calculate Pearson/Spearman correlation between H4K16ac signal and gene expression

  • Binary classification: Define H4K16ac-positive and -negative genes, compare expression distributions

  • Machine learning: Use H4K16ac and other features to predict expression (Random Forest, SVM)

  • Multivariate analysis: Principal Component Analysis with multiple histone marks

• Chromatin state analysis:

  • Use ChromHMM or Segway to define chromatin states including H4K16ac

  • Correlate states with expression, accessibility, and other functional measures

  • Identify state transitions associated with gene regulation

• H4K16ac in enhancer function:

  • Overlay H4K16ac with enhancer marks (H3K4me1, H3K27ac)

  • Correlate enhancer H4K16ac with target gene expression

  • Use chromatin conformation data (Hi-C, ChIA-PET) to link enhancers to promoters

• Biological pathway analysis:

  • Identify pathways enriched in genes with high H4K16ac

  • Compare pathway enrichment across experimental conditions

  • Gene Set Enrichment Analysis using H4K16ac signal as ranking metric

• Software tools for integration:

  • deepTools for correlation analysis and visualization

  • GenomicRanges (R/Bioconductor) for genomic data integration

  • ENCODE or Roadmap Epigenomics resources for comparative analysis

These integrative approaches help establish the functional significance of H4K16ac patterns in different biological contexts and regulatory networks .

What are the challenges in quantifying H4K16ac in different experimental contexts?

Quantifying H4K16ac presents several technical and analytical challenges:

• Antibody-based quantification limitations:

  • Batch-to-batch variability affects quantitative comparisons

  • Epitope accessibility may vary across chromatin states

  • Signal saturation at high antibody concentrations

  • Cross-reactivity with other acetylation sites

• Western blot quantification challenges:

  • Limited dynamic range of detection

  • Normalization to total H4 is essential but sometimes difficult

  • Signal linearity issues at very high or low expression levels

• ChIP-seq quantification issues:

  • Global changes affect normalization assumptions

  • Input normalization may be insufficient for comparative analysis

  • Spike-in controls are recommended for quantitative comparisons

  • Sequencing depth affects sensitivity for detecting low-enrichment regions

• Mass spectrometry considerations:

  • More accurate for quantification but technically challenging

  • Requires specialized equipment and expertise

  • Sample preparation can affect modification stability

  • Limited sensitivity for low-abundance modifications

• Spatial resolution limitations:

  • IF/ICC provides cellular resolution but limited quantitative accuracy

  • ChIP provides genomic location but limited spatial resolution

  • Single-cell methods are emerging but technically challenging

• Temporal dynamics:

  • H4K16ac levels can change rapidly

  • Capturing kinetics requires careful experimental design

  • Cell cycle effects must be controlled or accounted for

• Solution approaches:

  • Use multiple detection methods when possible

  • Include appropriate controls in every experiment

  • Consider targeted MS for absolute quantification

  • Use Acetyl-Histone H4 (K16) Quantification Kits for standardized global measurement

Understanding these challenges allows researchers to design more robust experiments and interpret results with appropriate caution .